Increased pY580-SHP2 expression was observed when cancer patients from progressive stages (stage I to IV) were examined (Fig. 6a, b), with significantly higher expression in stage IV, as compared to stages I to III (Supplementary Fig. S12c). The gene discussed is PTPN11; the disease is cancer.